Your browser doesn't support javascript.
Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register.
Poli, Daniela; Antonucci, Emilia; Ageno, Walter; Prandoni, Paolo; Barillari, Giovanni; Bitti, Giuseppina; Imbalzano, Egidio; Bucherini, Eugenio; Chistolini, Antonio; Fregoni, Vittorio; Galliazzo, Silvia; Gandolfo, Alberto; Grifoni, Elisa; Mastroianni, Franco; Panarello, Serena; Pesavento, Raffaele; Pedrini, Simona; Sala, Girolamo; Pignatelli, Pasquale; Preti, Paola; Simonetti, Federico; Sivera, Piera; Visonà, Adriana; Villalta, Sabina; Marcucci, Rossella; Palareti, Gualtiero.
  • Poli D; SOD Malattie Aterotrombotiche, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
  • Antonucci E; Fondazione Arianna Anticoagulazione, Bologna, Italy.
  • Ageno W; Dipartimento di Medicina e Chirurgia, Università dell'Insubria, Varese, Italy.
  • Prandoni P; Fondazione Arianna Anticoagulazione, Bologna, Italy.
  • Barillari G; Medicina Trasfusionale ASU FC Udine.
  • Bitti G; Medicina Interna Ospedale Civile di Fermo, Fermo, Italy.
  • Imbalzano E; A.O.U. G. Martino, Università di Messina, Messina, Italy.
  • Bucherini E; SS Az.le di Angiologia AUSL Romagna, Faenza (RA), Italy.
  • Chistolini A; Dipartimento di Medicina Traslazionale e di Precisione, Sapienza Università di Roma, Roma, Italy.
  • Fregoni V; U.O.C. Medicina Generale, ASST Valtellina e Alto Lario Ospedale di Sondalo, Italy.
  • Galliazzo S; UOC Medicina Generale, Ospedale San Valentino, Montebelluna (TV), Italy.
  • Gandolfo A; SC (UCO) Clinica Medica, ASUGI, Ospedale di Cattinara, Trieste, Italy.
  • Grifoni E; Medicina Interna 2, Ospedale San Giuseppe, Empoli (Fi), Italy.
  • Mastroianni F; UOC Medicina Interna, Covid Unit, EE Ospedale F. Miulli, Acquaviva delle Fonti (Ba), Italy.
  • Panarello S; SC Medicina Interna, Ospedale Galliera Genova, Italy.
  • Pesavento R; UO Clinica Medica 3 Azienda Ospedaliero Universitaria Padova, Italy.
  • Pedrini S; UO, laboratorio Analisi, Fondazione Poliambulanza Brescia, Italy.
  • Sala G; UOC Medicina II, Ospedale di Circolo Busto Arsizio (Va), Italy.
  • Pignatelli P; I Clinica Medica, Medicina Interna Covid e Centro Trombosi Sapienza, Università di Roma, Roma, Italy.
  • Preti P; Unità di Medicina Interna, Malattie Vascolari e Metaboliche Policlinico San Matteo, Pavia, Italy.
  • Simonetti F; UOC Ematologia Aziendale - Ospedale Versilia -Lido di Camaiore (Lucca), Italy.
  • Sivera P; SCDU Ematologia e terapie cellulari, AO Ordine Mauriziano Umberto 1° Torino, Italy.
  • Visonà A; UOC Angiologia, Ospedale San Giacomo Apostolo, Castelfranco Veneto (Treviso), Italy.
  • Villalta S; UOC Medicina Generale, Ospedale San Giacomo Apostolo, Castelfranco Veneto (Treviso), Italy.
  • Marcucci R; SOD Malattie Aterotrombotiche, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
  • Palareti G; Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.
TH Open ; 6(3): e251-e256, 2022 Jul.
Article in English | MEDLINE | ID: covidwho-2062315
ABSTRACT
Background Coronavirus disease 2019 (COVID-19) infection causes acute respiratory insufficiency with severe interstitial pneumonia and extrapulmonary complications; in particular, it may predispose to thromboembolic disease. The reported incidence of thromboembolic complications varies from 5 to 30% of cases. Aim We conducted a multicenter, Italian, retrospective, observational study on COVID-19 patients admitted to ordinary wards, to describe the clinical characteristics of patients at admission and bleeding and thrombotic events occurring during the hospital stay. Results The number of hospitalized patients included in the START-COVID-19 Register was 1,135, and the number of hospitalized patients in ordinary wards included in the study was 1,091, with 653 (59.9%) being males and 71 years (interquartile range 59-82 years) being the median age. During the observation, two (0.2%) patients had acute coronary syndrome episodes and one patient (0.1%) had an ischemic stroke; no other arterial thrombotic events were recorded. Fifty-nine patients had symptomatic venous thromboembolism (VTE) (5.4%) events, 18 (30.5%) deep vein thrombosis (DVT), 39 (66.1%) pulmonary embolism (PE), and 2 (3.4%) DVT+PE. Among patients with DVT, eight (44.4%) were isolated distal DVT and two cases were jugular thrombosis. Among patients with PE, seven (17.9%) events were limited to subsegmental arteries. No fatal PE was recorded. Major bleeding events occurred in nine (1.2%) patients and clinically relevant nonmajor bleeding events in nine (1.2%) patients. All bleeding events occurred among patients receiving thromboprophylaxis, more frequently when treated with subtherapeutic or therapeutic dosages. Conclusion Our findings confirm that patients admitted to ordinary wards for COVID-19 infection are at high risk for thromboembolic events. VTE recorded among these patients is mainly isolated PE, suggesting a peculiar characteristic of VTE in these patients.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: TH Open Year: 2022 Document Type: Article Affiliation country: A-1878-6806

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: TH Open Year: 2022 Document Type: Article Affiliation country: A-1878-6806